Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions
- PMID: 27235612
- DOI: 10.1016/j.mcna.2016.03.001
Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions
Abstract
Disease-modifying antirheumatic drugs (DMARDs) are commonly prescribed by rheumatologists to reduce disease activity and induce remission in autoimmune conditions such as systemic lupus erythematosus and rheumatoid arthritis. Steroids are sometimes used in combination with DMARD therapy and should be used at the lowest effective dose for the least amount of time. There are many biologic agents available for use for inflammatory arthritis and other autoimmune conditions. Care should be taken when prescribing and managing DMARDS, steroids and biologic agents medications with a careful eye towards screening for infectious disease, vaccination, bone heath and lab monitoring.
Keywords: Autoimmune; Biologic agents; Disease-modifying antirheumatic drugs (DMARDs); Gout; Immunosuppression; Rheumatology.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Is there still a role for traditional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis?Curr Opin Rheumatol. 2003 May;15(3):185-92. doi: 10.1097/00002281-200305000-00003. Curr Opin Rheumatol. 2003. PMID: 12707569 Review.
-
Treatment of acute gout.Rheum Dis Clin North Am. 2014 May;40(2):329-41. doi: 10.1016/j.rdc.2014.01.008. Epub 2014 Feb 19. Rheum Dis Clin North Am. 2014. PMID: 24703350 Review.
-
From aspirin to biologics: therapeutic implications for rheumatoid arthritis.J Rheumatol Suppl. 1992 Jan;32:95-7. J Rheumatol Suppl. 1992. PMID: 1613740
-
Update on methotrexate as the anchor drug for rheumatoid arthritis.Bull Hosp Jt Dis (2013). 2013;71 Suppl 1:S9-19. Bull Hosp Jt Dis (2013). 2013. PMID: 24219036 Review.
-
[Drug therapy of rheumatoid arthritis].Orthopade. 2003 Dec;32(12):1095-103. doi: 10.1007/s00132-003-0560-9. Orthopade. 2003. PMID: 14655006 Review. German.
Cited by
-
Proteolysis by Granzyme B Enhances Presentation of Autoantigenic Peptidylarginine Deiminase 4 Epitopes in Rheumatoid Arthritis.J Proteome Res. 2017 Jan 6;16(1):355-365. doi: 10.1021/acs.jproteome.6b00617. Epub 2016 Oct 20. J Proteome Res. 2017. PMID: 27700100 Free PMC article.
-
Trends in healthcare utilization by patients with gout: A cross-sectional study using Health Insurance Review and Assessment Service data.Medicine (Baltimore). 2024 Feb 16;103(7):e36436. doi: 10.1097/MD.0000000000036436. Medicine (Baltimore). 2024. PMID: 38363901 Free PMC article.
-
A novel approach to hypophysitis: outcomes using non-glucocorticoid immunosuppressive therapy.Eur J Endocrinol. 2023 Sep 1;189(3):309-317. doi: 10.1093/ejendo/lvad115. Eur J Endocrinol. 2023. PMID: 37602514 Free PMC article. Review.
-
Prescription duration and treatment episodes in oral glucocorticoid users: application of the parametric waiting time distribution.Clin Epidemiol. 2017 Nov 16;9:591-600. doi: 10.2147/CLEP.S148671. eCollection 2017. Clin Epidemiol. 2017. PMID: 29180903 Free PMC article.
-
Research progress of engineered mesenchymal stem cells and their derived exosomes and their application in autoimmune/inflammatory diseases.Stem Cell Res Ther. 2023 Apr 11;14(1):71. doi: 10.1186/s13287-023-03295-7. Stem Cell Res Ther. 2023. PMID: 37038221 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
